Amicus, Inc.
Amicus, Inc., a leading player in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2002, the company has made significant strides in developing innovative therapies for rare genetic disorders, particularly focusing on enzyme replacement therapies. Amicus is renowned for its flagship product, Galafold, which offers a unique treatment approach for Fabry disease, setting it apart in the competitive landscape. With a commitment to advancing patient care, Amicus has achieved notable milestones, including successful clinical trials and strategic partnerships that enhance its market position. As a pioneer in the biopharmaceutical industry, Amicus, Inc. continues to drive progress in the treatment of complex diseases, solidifying its reputation as a trusted name in biotechnology.
DitchCarbon Score
How does Amicus, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amicus, Inc.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Amicus, Inc.'s reported carbon emissions
Amicus, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of defined emissions metrics, it is essential for Amicus, Inc. to establish clear climate commitments and reduction initiatives to align with industry standards and expectations for sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Amicus, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
